kabutan

ADR120S,Inc.(3750) Summary

3750
TSE Standard
ADR120S,Inc.
828
JPY
-7
(-0.84%)
Apr 28, 3:30 pm JST
5.20
USD
Apr 28, 2:30 am EDT
Result
PTS
outside of trading hours
Summary Chart Historical News Financial Result
PER
PBR
73.2
Yield
ー%
Margin Trading Ratio
Stock Price
Apr 28, 2026
Opening Apr 28, 9:00 am
820 JPY 5.14 USD
Previous Close Apr 27
835 JPY 5.23 USD
High Apr 28, 3:05 pm
833 JPY 5.23 USD
Low Apr 28, 9:39 am
810 JPY 5.08 USD
Volume
2,900
Trading Value
2.00M JPY 0.01M USD
VWAP
818.0 JPY 5.13 USD
Minimum Trading Value
82,800 JPY 520 USD
Market Cap
7.39B JPY 0.05B USD
Number of Trades
23
Liquidity & Number of Trades
As of Apr 28, 2026
Liquidity
Slightly Low
1-Year Average
28
1-Year High Jul 4, 2025
344
Margin Trading
Date Short Interest Long Margin Positions Ratio
Apr 24, 2026 0 1,486,300
Apr 17, 2026 0 1,748,800
Apr 10, 2026 0 1,948,600
Apr 3, 2026 0 1,949,600
Mar 27, 2026 0 1,948,200
Company Profile
Cytori Cell Research Institute, Inc. has shifted its focus to regenerative medicine, medical devices, and medical tourism as its main business areas. The company is withdrawing from real estate and hotel operations.
Sector
Information & Communication
Cytori Cell Research Institute, Inc. is developing a medical business that invests in medical assets. The company sells medical devices such as Celution centrifuges and cell therapy kits to domestic medical institutions and university hospitals. In 2022, the company obtained domestic manufacturing and sales approval for the Celution Cell Therapy Kit, a highly controlled medical device, as a treatment for male stress urinary incontinence. Cytori Cell Research Institute, Inc. is withdrawing from real estate and hotel businesses, concentrating its management resources on the medical field.